Indolizine compounds for the treatment of mental disorders or mental enhancement
Номер патента: EP4426291A1
Опубликовано: 11-09-2024
Автор(ы): Matthew BAGGOTT
Принадлежит: Tactogen Inc
Опубликовано: 11-09-2024
Автор(ы): Matthew BAGGOTT
Принадлежит: Tactogen Inc
Реферат: The present invention discloses a compound, composition, method for modulating central nervous system activity, or method for treating central nervous system disorders, such as post- traumatic stress and adjustment disorders, comprising an indolizine-containing compound having a structure disclosed herein.
Heterocyclic compounds for the inhibition and treatment of sphingosine-1-phosphate mediated diseases
Номер патента: CA3005236C. Автор: Raju Mohan,Jason Harris,John Nuss. Владелец: Oppilan Pharma Ltd. Дата публикации: 2024-02-20.